Search research articles
Contact Us
Filters
Showing results (121-130 of 156) with videos related to
Page
of 16
Sort By:
Cancer Gene Therapy
|
July 27, 1999
DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in mice
F Neglia, A M Orengo, M Cilli, et al.
Cancer Research
|
March 27, 1998
Interleukin 12 gene therapy of MHC-negative murine melanoma metastases
P Nanni, I Rossi, C De Giovanni, et al.
British Journal of Cancer
|
November 1, 1995
Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin
C De Giovanni, C Melani, P Nanni, et al.
La Ricerca in Clinica E in Laboratorio
|
January 1, 1986
Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studies
G Parmiani, M L Sensi, A Balsari, et al.
Cancer Research
|
September 29, 1998
Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody
C Melani, M Figini, D Nicosia, et al.
Human Gene Therapy
|
October 20, 1996
Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells
F Arienti, J Sulé-Suso, F Belli, et al.
Folia Biologica
|
January 1, 1996
Cytokine-based gene therapy of human tumors. An overview
G Parmiani, F Arienti, J Sulé-Suso, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1994
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4
F Pericle, M Giovarelli, M P Colombo, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
November 24, 2020
Intestinal Inflammation is Linked to Hypoacetylation of Histone 3 Lysine 27 and can be Reversed by Valproic Acid Treatment in Inflammatory Bowel Disease Patients
C Felice, A Lewis, S Iqbal, et al.
Natural Immunity
|
March 1, 1994
Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes
P Musiani, A Modesti, M Brunetti, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 156) with videos related to
Sort By:
Page
of 16
Cancer Gene Therapy
|
July 27, 1999
DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in mice
F Neglia, A M Orengo, M Cilli, et al.
Cancer Research
|
March 27, 1998
Interleukin 12 gene therapy of MHC-negative murine melanoma metastases
P Nanni, I Rossi, C De Giovanni, et al.
British Journal of Cancer
|
November 1, 1995
Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin
C De Giovanni, C Melani, P Nanni, et al.
La Ricerca in Clinica E in Laboratorio
|
January 1, 1986
Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studies
G Parmiani, M L Sensi, A Balsari, et al.
Cancer Research
|
September 29, 1998
Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody
C Melani, M Figini, D Nicosia, et al.
Human Gene Therapy
|
October 20, 1996
Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells
F Arienti, J Sulé-Suso, F Belli, et al.
Folia Biologica
|
January 1, 1996
Cytokine-based gene therapy of human tumors. An overview
G Parmiani, F Arienti, J Sulé-Suso, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1994
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4
F Pericle, M Giovarelli, M P Colombo, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
November 24, 2020
Intestinal Inflammation is Linked to Hypoacetylation of Histone 3 Lysine 27 and can be Reversed by Valproic Acid Treatment in Inflammatory Bowel Disease Patients
C Felice, A Lewis, S Iqbal, et al.
Natural Immunity
|
March 1, 1994
Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes
P Musiani, A Modesti, M Brunetti, et al.
Page
of 16